Home › Alopecia Areata › New York › New York City
Alopecia Areata clinical trials in New York City, NY
4 studies for Alopecia Areata are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Dupilumab in the Treatment of Pediatric Alopecia Areata
RecruitingPhase 2
- Icahn School of Medicine at Mount Sinai, New York
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
RecruitingPhase 3
- Equity Medical /ID# 266680, New York
- Sadick Research Group LLC /ID# 266790, New York
Regeneron AA Multicenter (Dupilumab)
RecruitingPhase 2
- Icahn School of Medicine at Mount Sinai, New York
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
RecruitingPhase 2
- Icahn School of Medicine at Mount Sinai, New York
Alopecia Areata trials in other cities
- Indianapolis, IN7 studies
- Miami, FL6 studies
- San Antonio, TX6 studies
- Omaha, NE5 studies
- Spokane, WA3 studies
- Columbus, OH3 studies
- Irvine, CA3 studies
- Houston, TX3 studies
- Troy, MI3 studies
- Los Angeles, CA3 studies
- Portland, OR3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.